Saving changes...

Done

Error

Challenges in HIV/HCV Co-Infection:A Case Study

Challenges in HIV/HCV Co-Infection:A Case Study

Challenges in HIV/HCV Co-Infection:A Case Study

Alftan  Dyson, PharmD, BCACP, AAHIVP
Alftan Dyson, PharmD, BCACP, AAHIVP
on behalf of Postgraduate Healthcare Education, LLC

FREE
FREE
FREE

FREE
FREE
FREE

null FREE
FREE
FREE
null FREE
FREE
FREE
Normal Price: FREE FREE

Review:

Launch date: 13 Mar 2017
Expiry Date:

Last updated: 03 Jan 2018

Reference: 172109

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections are both chronic conditions that can be life-threatening if left untreated. Patients with both conditions benefit from advances in antiviral therapy, which are highly effective, leading to undetectable viral load (HIV) and possible "cure" (HCV) if they are taken with excellent adherence. Both treatment regimens incur substantial cost, have important drug-drug interactions (with each other and with other drug classes), and notable side effects, but while HIV treatment is lifelong, newer HCV treatments are given for a relatively short duration (12 weeks). HIV/HCV co-infected patients are susceptible to significant barriers to medication access and adherence and can be one of the toughest clinical challenges faced by pharmacists. Yet, the opportunity for excellent clinical results exists when all aspects of the cascade of care are addressed. This interactive case module will review the current treatment recommendations for patients with HIV/HCV co-infection and discuss barriers to care and strategies to overcome these barriers using a case study to highlight common challenges in a real-world scenario.

Objectives

Objectives
At the conclusion of this activity, the participant should be able to:

-Assess individualized treatment plans for HCV/HIV treatment and associated monitoring parameters.
-Recognize patient-specific access to medication issues relevant to drug therapy selection and modifications.
-Evaluate HIV and HCV regimens for identification and clinical management of DDIs.
Alftan  Dyson, PharmD, BCACP, AAHIVP

Author Information Play Video Bio

Alftan Dyson, PharmD, BCACP, AAHIVP
on behalf of Postgraduate Healthcare Education, LLC

Alftan Dyson, PharmD, BCACP, AAHIVP (Chair/Author) Manager, Walgreens Specialty Pharmacy Montgomery

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Pharmacy Education (ACPE)
  • 0.50 Hours -
    Reference: 0064-0000-17-202-H02-P

Faculty and Disclosures

Additional Contributors

null

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error